Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 474,545	$ 329,011
Receivables	87,580	69,276
Real estate inventories	3,012,622	3,065,436
Investments in unconsolidated entities	36,040	11,745
Goodwill and other intangible assets, net	159,626	159,893
Deferred tax assets, net	39,744	49,904
Other assets	167,747	173,425
Total assets	3,977,904	3,858,690
Liabilities
Accounts payable	71,086	66,120
Accrued expenses and other liabilities	314,818	322,043
Loans payable	250,000	250,000
Senior notes, net	1,166,189	1,033,985
Total liabilities	1,802,093	1,672,148
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively	0	0
Common stock, $0.01 par value, 500,000,000 shares authorized;    130,325,865 and 136,149,633 shares issued and outstanding at    June 30, 2020 and December 31, 2019, respectively	1,303	1,361
Additional paid-in capital	482,111	581,195
Retained earnings	1,692,385	1,603,974
Total stockholders’ equity	2,175,799	2,186,530
Noncontrolling interests	12	12
Total equity	2,175,811	2,186,542
Total liabilities and equity	$ 3,977,904	$ 3,858,690